Italia markets closed

NARI May 2024 35.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,10000,0000 (0,00%)
Alla chiusura: 03:44PM EDT
Schermo intero
Chiusura precedente0,1000
Aperto0,2500
Denaro0,0500
Lettera0,2000
Prezzo d'esercizio35,00
Scadenza2024-05-17
Min-Max giorno0,0500 - 0,2500
Contratto - Min-MaxN/D
Volume2.537
Open Interest655
  • GlobeNewswire

    Inari Medical to Announce Third Quarter 2023 Financial Results

    IRVINE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its third quarter 2023 financial results on Wednesday, November 1, 2023. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and

  • GlobeNewswire

    Inari Medical to Present at Upcoming Investor Conferences

    IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the following investor conferences: 2023 Wells Fargo Healthcare ConferencePresenting on Friday, September 8, 2023 at 8:45 a.m. Eastern Time in Boston, MA at the Encore Boston Harbor 21st Annual Morgan Stanley Global Heal

  • GlobeNewswire

    Inari Medical Reports Second Quarter 2023 Financial Results

    IRVINE, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its second quarter ended June 30, 2023. Second Quarter Financial and Recent Business Highlights Generated revenue of $119.0 million in Q2 of 2023, up 28.3% over the same quarter last year.Delivered net income of $2.1 million in Q2 of 2023,